Biosimilars in the Americas: the future by consensus
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Rheumatology"
DOI: 10.1007/s10067-019-04549-7
Abstract: The development of biologic agents, proteins engineered to specifically target key components of the inflammatory pathway, heralded a new era in the management of rheumatic diseases. With impressively high efficacy, especially in combination with methotrexate,… read more here.
Keywords: future consensus; biosimilars americas; consensus; americas future ... See more keywords